Meredith works at Charles River’s Hanover, MD site, a contract manufacturing and development organization (CDMO) that focuses on cell and gene therapies. Her projects have included mesenchymal stem cells, cancer cell lines, and primary immune cells.
Meredith’s career began with studying hematopoiesis and characterizing leukemias at Becton Dickinson using flow cytometry. She further studied hematopoiesis, oncology, and immunology as a graduate student at Johns Hopkins University. She came to Charles River from Johns Hopkins University’s Advanced Academic Programs where she served as Assistant Director and Senior Lecturer for the MS in Biotechnology Program. Courses taught included Cancer Biology, Cancer Genomics, Immunology, and Regenerative Stem Cell Biology.
Meredith has a PhD in Biology from Johns Hopkins University and an MS in Healthcare Management from Johns Hopkins Carey Business School. Her post-doctoral fellowship research projects at Johns Hopkins School of Medicine and at the National Institute on Aging focused on T cell activation and anergy induction. Before joining Johns Hopkins as a faculty member, Meredith gained scientific publication experience working on the editorial staff of the Journal of Immunology.